Rossella Fioravanti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY	2022
Current HDAC Inhibitors in Clinical Trials	CHIMIA	2022
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni	ACS INFECTIOUS DISEASES	2022
Bovine serum amine oxidase and polyamine analogues: chemical synthesis and biological evaluation integrated with molecular docking and 3-D QSAR studies	JOURNAL OF CHEMICAL INFORMATION AND MODELING	2022
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2022
Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5	JOURNAL OF MEDICINAL CHEMISTRY	2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduced Viability in Worm Larval and Adult Stages	CHEMMEDCHEM	2022
PD-L1 small-molecule modulators: a new hope in epigenetic-based multidrug cancer therapy?	DRUG DISCOVERY TODAY	2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2022
Selenium-Containing Agents Acting on Cancer—A New Hope?	PHARMACEUTICS	2022
Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation	CANCERS	2020
Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation	CHEMMEDCHEM	2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation	SCIENCE ADVANCES	2020
Design of first-in-class dual EZH2/HDAC inhibitor: biochemical activity and biological evaluation in cancer cells	ACS MEDICINAL CHEMISTRY LETTERS	2020
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)	CURRENT OPINION IN CHEMICAL BIOLOGY	2020
Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 Inhibitors and Induced apoptosis in cancer cells	MOLECULES	2020
CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas	FRONTIERS IN PHARMACOLOGY	2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity	CHEMMEDCHEM	2020
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells	CLINICAL EPIGENETICS	2019
design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol-4-yl-methylaniline derivatives	FRONTIERS IN CHEMISTRY	2019

ERC

PE5_18

KET

Life-science technologies & biotechnologies

Laboratori di ricerca

LABORATORIO 116